{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T12:57:21Z","timestamp":1781873841036,"version":"3.54.5"},"reference-count":35,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T00:00:00Z","timestamp":1781827200000},"content-version":"unspecified","delay-in-days":169,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006546","name":"Angelini Pharma","doi-asserted-by":"publisher","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"10.13039\/501100006546","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Neurol Open"],"accepted":{"date-parts":[[2026,5,11]]},"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Epilepsy and depression are prevalent, chronic conditions with a complex, bidirectional relationship that is not yet fully understood and contributes significantly to morbidity, mortality and healthcare burden. Despite advances in machine learning (ML) for analysing large real-world datasets, there is a lack of large-scale, multinational studies applying ML to explore the interplay between epilepsy and depression. This study aimed to identify predictors of depression in patients with epilepsy (PWE) and predictors of epilepsy in patients with depression (PWD), uncovering associations and shared risk factors across directions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This retrospective, observational cohort study analysed longitudinal patient-level data from Denmark, France, Germany, Italy, Spain, Sweden and the United Kingdom. Supervised ML models were trained separately within each country. Demographics (age, gender), clinical (diagnosis and prescription history), socioeconomic status (SES, which includes employment status, education level, disposable income, long-term sick leave\/financial state benefits, marital status) and healthcare utilisation features were used during training. Key predictors were identified using Shapley Additive Explanations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Approximately 2.2\u2009million PWE and 9.7\u2009million PWD were analysed across countries. Female gender, low SES and use of central nervous system (CNS) medications such as antipsychotics, anxiolytics and antimigraine agents were identified as predictors of depression in PWE. In PWD, epilepsy was associated with male gender, socioeconomic deprivation and use of selected CNS medications. Common predictors included demographics, socioeconomic factors and treatments for other CNS conditions, suggesting a shared higher multimorbidity burden.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This study demonstrates the potential of applying artificial intelligence to elucidate not only the multifactorial relationship between epilepsy and depression but also the interplay with other CNS disorders. The findings highlight the importance of demographic, clinical and social determinants in risk stratification and may assist development of screening tools for earlier intervention in high-risk patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjno-2025-001525","type":"journal-article","created":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T12:40:28Z","timestamp":1781872828000},"page":"e001525","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["AI-driven European Retrospective Database Study to predict disease onset in patients with epilepsy and depression"],"prefix":"10.1136","volume":"8","author":[{"given":"Alessandro","family":"Ruggieri","sequence":"first","affiliation":[{"name":"Global Medical Department, Angelini Pharma SpA, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John Paul","family":"Leach","sequence":"additional","affiliation":[{"name":"Global Medical Department, Angelini Pharma SpA, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Alvarez-Baron","sequence":"additional","affiliation":[{"name":"Global Medical Department, Angelini Pharma SpA, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Di Franco","sequence":"additional","affiliation":[{"name":"Global Medical Department, Angelini Pharma SpA, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline Clare","family":"Benoist","sequence":"additional","affiliation":[{"name":"Global Medical Department, Angelini Pharma SpA, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Comandini","sequence":"additional","affiliation":[{"name":"Global Medical Department, Angelini Pharma SpA, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgio","family":"Di Loreto","sequence":"additional","affiliation":[{"name":"Global Medical Department, Angelini Pharma SpA, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Lovera","sequence":"additional","affiliation":[{"name":"Global Medical Department, Angelini Pharma SpA, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Constandse","sequence":"additional","affiliation":[{"name":"Real-World and Commercial Services, IQVIA, Amsterdam, Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7599-4666","authenticated-orcid":false,"given":"Martina","family":"Pili","sequence":"additional","affiliation":[{"name":"Real-World and Commercial Services, IQVIA, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Gallinaro","sequence":"additional","affiliation":[{"name":"Real-World and Commercial Services, IQVIA, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pejman","family":"Farhadi Ghalati","sequence":"additional","affiliation":[{"name":"Real-World and Commercial Services, IQVIA, Frankfurt, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frida","family":"Bayard","sequence":"additional","affiliation":[{"name":"Real-World and Analytics Solutions, IQVIA, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdul Sattar","family":"Raslan","sequence":"additional","affiliation":[{"name":"Real-World and Commercial Services, IQVIA, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aisling","family":"O\u2019Loughlin","sequence":"additional","affiliation":[{"name":"Real-World and Commercial Services, IQVIA, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Balazs","family":"Vamosi","sequence":"additional","affiliation":[{"name":"Real-World and Commercial Services, IQVIA, Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnese","family":"Cattaneo","sequence":"additional","affiliation":[{"name":"Global Medical Department, Angelini Pharma SpA, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,6,19]]},"reference":[{"key":"2026061905401846000_8.1.e001525.1","unstructured":"World Health Organization . Epilepsy. Available: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/epilepsy [Accessed 30 Sep 2025]."},{"key":"2026061905401846000_8.1.e001525.2","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1212\/WNL.0000000000001005","article-title":"Epilepsy-related clinical characteristics and mortality: a systematic review and meta-analysis","volume":"83","author":"Nevalainen","year":"2014","journal-title":"Neurology (ECronicon)"},{"key":"2026061905401846000_8.1.e001525.3","unstructured":"World Health Organization . Depressive disorder (depression). Available: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/depression [Accessed 30 Sep 2025]."},{"key":"2026061905401846000_8.1.e001525.4","doi-asserted-by":"publisher","DOI":"10.1002\/ana.23601"},{"key":"2026061905401846000_8.1.e001525.5","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.yebeh.2018.04.015","article-title":"Major depressive disorder in epilepsy clinics: A meta-analysis","volume":"84","author":"Kim","year":"2018","journal-title":"Epilepsy & Behavior"},{"key":"2026061905401846000_8.1.e001525.6","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1001\/jamaneurol.2016.5042","article-title":"Association of Depression and Treated Depression With Epilepsy and Seizure Outcomes: A Multicohort Analysis","volume":"74","author":"Josephson","year":"2017","journal-title":"JAMA Neurol"},{"key":"2026061905401846000_8.1.e001525.7","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a022798","article-title":"Common Mechanisms Underlying Epileptogenesis and the Comorbidities of Epilepsy","volume":"6","author":"Mazarati","year":"2016","journal-title":"Cold Spring Harb Perspect Med"},{"key":"2026061905401846000_8.1.e001525.8","first-page":"1","article-title":"A Deep Convolutional Neural Network Method to Detect Seizures and Characteristic Frequencies Using Epileptic Electroencephalogram (EEG) Data","volume":"9","author":"Rashed-Al-Mahfuz","year":"2021","journal-title":"IEEE J Transl Eng Health Med"},{"key":"2026061905401846000_8.1.e001525.9","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.yebeh.2019.04.006","article-title":"Prediction of antiepileptic drug treatment outcomes of patients with newly diagnosed epilepsy by machine learning","volume":"96","author":"Yao","year":"2019","journal-title":"Epilepsy & Behavior"},{"key":"2026061905401846000_8.1.e001525.10","doi-asserted-by":"crossref","first-page":"108548","DOI":"10.1016\/j.yebeh.2021.108548","article-title":"Supervised machine learning to predict reduced depression severity in people with epilepsy through epilepsy self-management intervention","volume":"127","author":"Camp","year":"2022","journal-title":"Epilepsy Behav"},{"key":"2026061905401846000_8.1.e001525.11","unstructured":"Geographic Data Service . Index of Multiple Deprivation (IMD) - Geographic Data Service, Available: https:\/\/data.geods.ac.uk\/dataset\/index-of-multiple-deprivation-imd [Accessed 8 Oct 2025]."},{"key":"2026061905401846000_8.1.e001525.12","doi-asserted-by":"publisher","DOI":"10.1097\/01.mlr.0000182534.19832.83"},{"key":"2026061905401846000_8.1.e001525.13","doi-asserted-by":"crossref","unstructured":"Chen T , Guestrin C . XGBoost: a scalable tree boosting system. Proc. 22nd ACM SIGKDD Int. Conf. Knowl. Discov; 2016:785\u201394. doi:10.1145\/2939672.2939785 Available: https:\/\/doi.org\/10.1145\/2939672.2939785","DOI":"10.1145\/2939672.2939785"},{"key":"2026061905401846000_8.1.e001525.14","unstructured":"Ke G , Meng Q , Finley T , et al . LightGBM: A Highly Efficient Gradient Boosting Decision Tree. 2017."},{"key":"2026061905401846000_8.1.e001525.15","unstructured":"Snoek J , Larochelle H , Adams RP . Practical Bayesian Optimization of Machine Learning Algorithms. Adv Neural Inf Process Syst 2012;25."},{"key":"2026061905401846000_8.1.e001525.16","unstructured":"Lundberg S , Lee S-I . A unified approach to interpreting model predictions 2017. 2017. Available: https:\/\/doi.org\/10.48550\/arXiv.1705.07874"},{"key":"2026061905401846000_8.1.e001525.17","doi-asserted-by":"crossref","first-page":"107030","DOI":"10.1016\/j.yebeh.2020.107030","article-title":"Risk factors for depression in patients with epilepsy: A meta-analysis","volume":"106","author":"Yang","year":"2020","journal-title":"Epilepsy & Behavior"},{"key":"2026061905401846000_8.1.e001525.18","doi-asserted-by":"publisher","DOI":"10.1046\/j.1528-1157.2002.t01-1-26901.x"},{"key":"2026061905401846000_8.1.e001525.19","doi-asserted-by":"crossref","first-page":"e614","DOI":"10.1016\/S2468-2667(24)00132-4","article-title":"Assessing the extent and determinants of socioeconomic inequalities in epilepsy in the UK: a systematic review and meta-analysis of evidence","volume":"9","author":"Bush","year":"2024","journal-title":"Lancet Public Health"},{"key":"2026061905401846000_8.1.e001525.20","doi-asserted-by":"crossref","DOI":"10.1093\/epirev\/mxaf011","article-title":"Socioeconomic status and depression-a systematic review","volume":"47","author":"Jespersen","year":"2025","journal-title":"Epidemiol Rev"},{"key":"2026061905401846000_8.1.e001525.21","doi-asserted-by":"crossref","unstructured":"McHugh RK , Weiss RD . Alcohol Use Disorder and Depressive Disorders. ARCR 2019;40. doi:10.35946\/arcr.v40.1.01","DOI":"10.35946\/arcr.v40.1.01"},{"key":"2026061905401846000_8.1.e001525.22","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2018.00401","article-title":"Alcohol Use and Alcohol-Related Seizures in Patients With Epilepsy","volume":"9","author":"Hamerle","year":"2018","journal-title":"Front Neurol"},{"key":"2026061905401846000_8.1.e001525.23","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(15)00225-2"},{"key":"2026061905401846000_8.1.e001525.24","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2020.20030305"},{"key":"2026061905401846000_8.1.e001525.25","doi-asserted-by":"crossref","DOI":"10.1186\/s10194-019-0988-x","article-title":"Understanding the nature of psychiatric comorbidity in migraine: a systematic review focused on interactions and treatment implications","volume":"20","author":"Dresler","year":"2019","journal-title":"J Headache Pain"},{"key":"2026061905401846000_8.1.e001525.26","doi-asserted-by":"crossref","DOI":"10.1186\/s10194-024-01719-0","article-title":"Migraine - a borderland disease to epilepsy: near it but not of it","volume":"25","author":"Paungarttner","year":"2024","journal-title":"J Headache Pain"},{"key":"2026061905401846000_8.1.e001525.27","doi-asserted-by":"publisher","DOI":"10.1111\/ene.12612"},{"key":"2026061905401846000_8.1.e001525.28","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2021.12.134"},{"key":"2026061905401846000_8.1.e001525.29","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.seizure.2012.10.009","article-title":"Antipsychotics and seizures: higher risk with atypicals?","volume":"22","author":"Lertxundi","year":"2013","journal-title":"Seizure"},{"key":"2026061905401846000_8.1.e001525.30","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/ene.13813","article-title":"Stroke-related epilepsy","volume":"26","author":"Feyissa","year":"2019","journal-title":"Eur J Neurol"},{"key":"2026061905401846000_8.1.e001525.31","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.yebeh.2005.12.005","article-title":"Risk factors for depression in patients with epilepsy","volume":"8","author":"Grabowska-Grzyb","year":"2006","journal-title":"Epilepsy & Behavior"},{"key":"2026061905401846000_8.1.e001525.32","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.yebeh.2004.01.010","article-title":"The impact of comorbid depression on health resource utilization in a community sample of people with epilepsy","volume":"5","author":"Cramer","year":"2004","journal-title":"Epilepsy & Behavior"},{"key":"2026061905401846000_8.1.e001525.33","unstructured":"SNOMED International, Available: https:\/\/www.snomed.org [Accessed 8 Oct 2025]."},{"key":"2026061905401846000_8.1.e001525.34","unstructured":"Federal Institute for Drugs and Medical Devices . BfArM - ATC, Available: https:\/\/www.bfarm.de\/EN\/Code-systems\/Classifications\/ATC\/_node.html [Accessed 8 Oct 2025]."},{"key":"2026061905401846000_8.1.e001525.35","unstructured":"BNF . NICE. National Institute for Health andCare Excellence, Available: https:\/\/www.nice.org.uk\/bnf-uk-only [Accessed 8 Oct 2025]."}],"container-title":["BMJ Neurology Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjno-2025-001525","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T12:40:35Z","timestamp":1781872835000},"score":1,"resource":{"primary":{"URL":"https:\/\/neurologyopen.bmj.com\/lookup\/doi\/10.1136\/bmjno-2025-001525"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,6,19]]},"published-print":{"date-parts":[[2026,1]]}},"alternative-id":["10.1136\/bmjno-2025-001525"],"URL":"https:\/\/doi.org\/10.1136\/bmjno-2025-001525","relation":{},"ISSN":["2632-6140"],"issn-type":[{"value":"2632-6140","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]}}}